Investment
Features
FeesSafety
Academy
More
Pluang+

VolitionRx reports Q1 revenue growth to $1M and advances clinical tests for cancer and chronic diseases.

Company Fundamentals
14 May 2026
PRNewsWire
View Source
Bullish
pluang ai news

VolitionRx Limited announced a revenue increase to approximately $1 million in Q1 2026, up from $0.2 million in the same period last year, while reducing operating loss by 3%. The company highlighted progress in its Nu.Q® Vet feline lymphoma test, which could unlock a $5 million milestone payment upon publication in a peer-reviewed journal. VolitionRx is also advancing reimbursement submissions for its Nu.Q® Lung Cancer test and exploring new clinical uses for its Nu.Q® NETs assay in trauma and chronic disease management. The company is actively negotiating licensing agreements with diagnostic firms to generate revenue through milestones and royalties, signaling strong commercial interest, especially in its Capture-Seq™ technology. A conference call is scheduled for May 15 to discuss these results and future milestones.

More News

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...

Market News
Bullish
3 hours ago
B&M's Q1 update splits analysts as Deutsche Bank upgrades but Panmure Liberum downgrades on growth doubts

B&M's Q1 update splits analysts as Deutsche Bank upgrades but Panmure Liberum downgrades on growth doubts

B&M European Value Retail's first-quarter update has divided analysts, with Deutsche Bank upgrading the stock to 'hold' citing stabilizing profit margins and a sensible turnaround strategy by new CEO Tjeerd Jegen. Deutsche Bank raised its profit fore...

Analyst Insights
Neutral
4 hours ago
Telo Genomics reports positive interim results for blood test predicting relapse risk in multiple myeloma patients.

Telo Genomics reports positive interim results for blood test predicting relapse risk in multiple myeloma patients.

Telo Genomics announced positive interim results from a clinical study analyzing blood samples of multiple myeloma patients to predict relapse risk using 3D telomere analysis. The test showed strong predictive accuracy, potentially offering a less in...

Market News
Bullish
4 hours ago
Meta alerts parents if teens discuss self-harm with its AI chatbot, plans emergency contact feature.

Meta alerts parents if teens discuss self-harm with its AI chatbot, plans emergency contact feature.

Meta now notifies parents if their teen talks about suicide or self-harm with its AI chatbot and is developing a feature to contact emergency services if risk is detected. This move addresses concerns about AI chatbots handling crisis conversations, ...

Market News
Neutral
4 hours ago
NTG Clarity nets $16.6M in new orders and renewals, boosting its digital services in Saudi Arabia.

NTG Clarity nets $16.6M in new orders and renewals, boosting its digital services in Saudi Arabia.

NTG Clarity Networks announced new purchase orders and contract renewals totaling about CAD 16.6 million, reflecting strong demand for its software development and digital transformation services. This includes $2.3 million from a real estate client ...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App